Analysis of CD34+ cells from another cohort with AML (n = 94; Supplementary Table 2) and normal donors (n = 19) confirmed PRMT9 upregulation (Extended Data Fig. 1r). This evidence concerns the gene PRMT9 and acute myeloid leukemia.